Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Developing PRISM: A Pragmatic Institutional Survey and Bench Marking Tool to Measure Digital Research Maturity of Cancer Centers.
Albiñana CB, Pallocca M, Fenton H, Sopwith W, Eden CV, Akre O, Auranen A, Bocquet F, Borges M, Calvo E, Corkett J, Di Cosimo S, Gentili N, Guérin J, Jor S, Kazda T, Kolar A, Kuschel T, Lostes MJ, Paratore C, Pedrazzoli P, Petrovic M, Raid J, Roche M, Schatz C, Thonnard J, Tonon G, Traverso A, Wolf A, Zedan AH, Mahon P. Albiñana CB, et al. Among authors: paratore c. Appl Clin Inform. 2024 Aug;15(4):743-750. doi: 10.1055/s-0044-1788331. Epub 2024 Sep 11. Appl Clin Inform. 2024. PMID: 39260412
Erratum: Developing PRISM: A Pragmatic Institutional Survey and Bench Marking Tool to Measure Digital Research Maturity of Cancer Centers.
Albiñana CB, Pallocca M, Fenton H, Sopwith W, Eden CV, Akre O, Auranen A, Bocquet F, Borges M, Calvo E, Corkett J, Di Cosimo S, Gentili N, Guérin J, Jor S, Kazda T, Kolar A, Kuschel T, Lostes MJ, Paratore C, Pedrazzoli P, Petrovic M, Raid J, Roche M, Schatz C, Thonnard J, Tonon G, Traverso A, Wolf A, Zedan AH, Mahon P. Albiñana CB, et al. Among authors: paratore c. Appl Clin Inform. 2024 Aug;15(4):e1. doi: 10.1055/s-0044-1792139. Epub 2024 Nov 4. Appl Clin Inform. 2024. PMID: 39496321 Free article. No abstract available.
Subgroup analyses in randomized phase III trials of systemic treatments in patients with advanced solid tumours: a systematic review of trials published between 2017 and 2020.
Paratore C, Zichi C, Audisio M, Bungaro M, Caglio A, Di Liello R, Gamba T, Gargiulo P, Mariniello A, Reale ML, Perrone F, Di Maio M. Paratore C, et al. ESMO Open. 2022 Dec;7(6):100593. doi: 10.1016/j.esmoop.2022.100593. Epub 2022 Oct 12. ESMO Open. 2022. PMID: 36228332 Free PMC article.
Analysis of the adequacy of control arms in oncology randomised clinical trials published between 2017 and 2021: a meta-research study.
Rossi A, Aimar G, Audisio M, Bungaro M, Caglio A, Di Liello R, Gamba T, Gargiulo P, Ghisoni E, Lombardi P, Marandino L, Mariniello A, Paratore C, Reale ML, Trastu F, Tuninetti V, Turco F, Fabi A, Perrone F, Di Maio M. Rossi A, et al. Among authors: paratore c. Eur J Cancer. 2023 Aug;189:112920. doi: 10.1016/j.ejca.2023.05.008. Epub 2023 May 15. Eur J Cancer. 2023. PMID: 37277262
Local for advanced, is this a paradox?
Bungaro M, Paratore C, Bironzo P, Novello S. Bungaro M, et al. Among authors: paratore c. Transl Lung Cancer Res. 2021 Jul;10(7):3324-3328. doi: 10.21037/tlcr-20-771. Transl Lung Cancer Res. 2021. PMID: 34430369 Free PMC article. No abstract available.
Second-line therapy in pancreatic ductal adenocarcinoma (PDAC) patients with germline BRCA1-2 pathogenic variants (gBRCA1-2pv).
Orsi G, Cavaliere A, Tortora G, Lonardi S, Macchini M, Di Marco M, Giordano G, Vasile E, Scartozzi M, Bozzarelli S, Noventa S, Rodriquenz MG, Militello AM, Rapposelli IG, Garajova I, De Lorenzo S, Merelli B, Bittoni A, Salvatore L, Procaccio L, Paratore C, Spallanzani A, Peretti U, Niger M, Giommoni E, Bernardini I, Tamburini E, Bernardino K, Forti L, Valente MM, Cascinu S, Milella M, Reni M. Orsi G, et al. Among authors: paratore c. Br J Cancer. 2023 Mar;128(5):877-885. doi: 10.1038/s41416-022-02086-w. Epub 2022 Dec 8. Br J Cancer. 2023. PMID: 36482190 Free PMC article.
Germinal BRCA1-2 pathogenic variants (gBRCA1-2pv) and pancreatic cancer: epidemiology of an Italian patient cohort.
Peretti U, Cavaliere A, Niger M, Tortora G, Di Marco MC, Rodriquenz MG, Centonze F, Rapposelli IG, Giordano G, De Vita F, Stuppia L, Avallone A, Ratti M, Paratore C, Forti LG, Orsi G, Valente MM, Gaule M, Macchini M, Carrera P, Calzavara S, Simbolo M, Melisi D, De Braud F, Salvatore L, De Lorenzo S, Chiarazzo C, Falconi M, Cascinu S, Milella M, Reni M. Peretti U, et al. Among authors: paratore c. ESMO Open. 2021 Feb;6(1):100032. doi: 10.1016/j.esmoop.2020.100032. Epub 2021 Jan 4. ESMO Open. 2021. PMID: 33399070 Free PMC article.
Chemotherapy toxicity and activity in patients with pancreatic ductal adenocarcinoma and germline BRCA1-2 pathogenic variants (gBRCA1-2pv): a multicenter survey.
Orsi G, Di Marco M, Cavaliere A, Niger M, Bozzarelli S, Giordano G, Noventa S, Rapposelli IG, Garajova I, Tortora G, Rodriquenz MG, Bittoni A, Penzo E, De Lorenzo S, Peretti U, Paratore C, Bernardini I, Mosconi S, Spallanzani A, Macchini M, Tamburini E, Bencardino K, Giommoni E, Scartozzi M, Forti L, Valente MM, Militello AM, Cascinu S, Milella M, Reni M. Orsi G, et al. Among authors: paratore c. ESMO Open. 2021 Oct;6(5):100238. doi: 10.1016/j.esmoop.2021.100238. Epub 2021 Aug 13. ESMO Open. 2021. PMID: 34392104 Free PMC article.
24 results